Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial
Authors
- Baoyu Feng (ORCID: https://orcid.org/0000-0003-1718-9025)
- Xuechun Wang
- Hao Li (ORCID: https://orcid.org/0000-0002-8591-4105)
- Yongjun Wang (ORCID: https://orcid.org/0000-0002-9976-2341)
- Shuya Li (ORCID: https://orcid.org/0000-0002-7263-0365)
Institutions
- Capital Medical University (CN)
- Beijing Tian Tan Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
Publication Details
- Journal
- Stroke and Vascular Neurology
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1136/svn-2025-004582
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China